Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 1 to 20 of 76

1.

HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment.

Singh KP, Crane M, Audsley J, Avihingsanon A, Sasadeusz J, Lewin SR.

AIDS. 2017 Sep 24;31(15):2035-2052. doi: 10.1097/QAD.0000000000001574. Review.

PMID:
28692539
2.

Error occurred: cannot get document summary

PMID:
28692541

3.

Unique microRNA expression in the colonic mucosa during chronic HIV-1 infection.

Fulcher JA, Koukos G, Koutsioumpa M, Elliott J, Drakaki A, Iliopoulos D, Anton PA.

AIDS. 2017 Sep 10;31(14):1925-1934. doi: 10.1097/QAD.0000000000001582.

PMID:
28692540
4.

Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients.

Lemoine M, Lacombe K, Bastard JP, Sébire M, Fonquernie L, Valin N, Fellahi S, Capeau J, Girard PM, Meynard JL.

AIDS. 2017 Sep 10;31(14):1955-1964. doi: 10.1097/QAD.0000000000001587.

PMID:
28692538
5.

Early initiation of antiretroviral treatment postSIV infection does not resolve lymphoid tissue activation.

Hong JJ, Silveira ELDV, Amancha PK, Byrareddy SN, Gumber S, Chang KT, Ansari AA, Villinger F.

AIDS. 2017 Aug 24;31(13):1819-1824. doi: 10.1097/QAD.0000000000001576.

PMID:
28692537
6.

Asymptomatic anorectal Chlamydia trachomatis and Neisseria gonorrhoeae infections are associated with systemic CD8+ T-cell activation.

Vieira VA, Avelino-Silva VI, Cerqueira NB, Costa DA, Costa PR, Vasconcelos RP, Madruga VR, Moreira RI, Hoagland B, Veloso VG, Grinsztejn B, Kallás EG; PrEP Brasil Study Team.

AIDS. 2017 Sep 24;31(15):2069-2076. doi: 10.1097/QAD.0000000000001580.

PMID:
28692536
7.

Error occurred: cannot get document summary

PMID:
28692535

8.

Blood neuron-derived exosomes as biomarkers of cognitive impairment in HIV.

Sun B, Dalvi P, Abadjian L, Tang N, Pulliam L.

AIDS. 2017 Sep 10;31(14):F9-F17. doi: 10.1097/QAD.0000000000001595.

PMID:
28692534
9.

Adverse events of raltegravir and dolutegravir.

Elzi L, Erb S, Furrer H, Cavassini M, Calmy A, Vernazza P, Günthard H, Bernasconi E, Battegay M; Swiss HIV Cohort Study Group.

AIDS. 2017 Aug 24;31(13):1853-1858. doi: 10.1097/QAD.0000000000001590.

10.

Cardiovascular outcomes among HIV-infected veterans receiving atazanavir.

LaFleur J, Bress AP, Rosenblatt L, Crook J, Sax PE, Myers J, Ritchings C.

AIDS. 2017 Sep 24;31(15):2095-2106. doi: 10.1097/QAD.0000000000001594.

11.

Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy.

Chappell CA, Lamorde M, Nakalema S, Chen BA, Mackline H, Riddler SA, Cohn SE, Darin KM, Achilles SL, Scarsi KK.

AIDS. 2017 Sep 10;31(14):1965-1972. doi: 10.1097/QAD.0000000000001591.

PMID:
28692531
12.

Limited overlap between phylogenetic HIV and hepatitis C virus clusters illustrates the dynamic sexual network structure of Dutch HIV-infected MSM.

Vanhommerig JW, Bezemer D, Molenkamp R, Van Sighem AI, Smit C, Arends JE, Lauw FN, Brinkman K, Rijnders BJ, Newsum AM, Bruisten SM, Prins M, Van Der Meer JT, Van De Laar TJ, Schinkel J; MOSAIC study and the ATHENA national observational cohort.

AIDS. 2017 Sep 24;31(15):2147-2158. doi: 10.1097/QAD.0000000000001592.

PMID:
28692530
13.

CYP2B6 genotypes and early efavirenz-based HIV treatment outcomes in Botswana.

Gross R, Bellamy SL, Ratshaa B, Han X, Vujkovic M, Aplenc R, Steenhoff AP, Mosepele M, Moorthy G, Zuppa AF, Strom BL, Bisson GP.

AIDS. 2017 Sep 24;31(15):2107-2113. doi: 10.1097/QAD.0000000000001593.

PMID:
28692529
14.

The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion.

Donnell D, Ramos E, Celum C, Baeten J, Dragavon J, Tappero J, Lingappa JR, Ronald A, Fife K, Coombs RW; Partners PrEP Study Team.

AIDS. 2017 Sep 10;31(14):2007-2016. doi: 10.1097/QAD.0000000000001577.

15.

Impact and economic evaluation of a novel HIV service delivery model in rural Malawi.

McBain RK, Petersen E, Tophof N, Dunbar EL, Kalanga N, Nazimera L, Mganga A, Dullie L, Mukherjee J, Wroe EB.

AIDS. 2017 Sep 10;31(14):1999-2006. doi: 10.1097/QAD.0000000000001578.

PMID:
28692543
16.

The effect of school attendance and school dropout on incident HIV and HSV-2 among young women in rural South Africa enrolled in HPTN 068.

Stoner MCD, Pettifor A, Edwards JK, Aiello AE, Halpern CT, Julien A, Selin A, Twine R, Hughes JP, Wang J, Agyei Y, Gomez-Olive FX, Wagner RG, MacPhail C, Kahn K.

AIDS. 2017 Sep 24;31(15):2127-2134. doi: 10.1097/QAD.0000000000001584.

PMID:
28692544
17.

Successful implementation of hepatitis C virus treatment in two large HIV clinics in Amsterdam: hepatitis C virus treatment cascade of care.

Saris J, van den Berk G, Moha DA, van der Meer J, Brinkman K, van der Valk M.

AIDS. 2017 Jul 31;31(12):1779-1780. doi: 10.1097/QAD.0000000000001566. No abstract available.

PMID:
28700397
18.

HIV-induced uveitis: would you recognize it if it looked straight at you?

Smit DP, Meyer D.

AIDS. 2017 Jul 31;31(12):1777-1779. doi: 10.1097/QAD.0000000000001564. No abstract available.

PMID:
28700396
19.

Neuropsychiatric events and dolutegravir in HIV patients: a worldwide issue involving a class effect.

Kheloufi F, Boucherie Q, Blin O, Micallef J.

AIDS. 2017 Jul 31;31(12):1775-1777. doi: 10.1097/QAD.0000000000001557. No abstract available.

PMID:
28700395
20.

Medication adherence, condom use and sexually transmitted infections in Australian preexposure prophylaxis users.

Lal L, Audsley J, Murphy DA, Fairley CK, Stoove M, Roth N, Moore R, Tee BK, Puratmaja N, Anderson PL, Leslie D, Grant RM, De Wit J, Wright E; VicPrEP Study Team.

AIDS. 2017 Jul 31;31(12):1709-1714. doi: 10.1097/QAD.0000000000001519.

PMID:
28700394

Supplemental Content

Support Center